000 01524 a2200433 4500
005 20250516225458.0
264 0 _c20150618
008 201506s 0 0 eng d
022 _a1539-2864
024 7 _a10.1097/IAE.0000000000000277
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWykoff, Charles C
245 0 0 _aProgressive retinal nonperfusion in ischemic central retinal vein occlusion.
_h[electronic resource]
260 _bRetina (Philadelphia, Pa.)
_cJan 2015
300 _a43-7 p.
_bdigital
500 _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAngiogenesis Inhibitors
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal, Humanized
_xtherapeutic use
650 0 4 _aDisease Progression
650 0 4 _aFemale
650 0 4 _aFluorescein Angiography
650 0 4 _aHumans
650 0 4 _aIschemia
_xdiagnosis
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aProspective Studies
650 0 4 _aRanibizumab
650 0 4 _aRetinal Vein
_xphysiopathology
650 0 4 _aRetinal Vein Occlusion
_xdiagnosis
650 0 4 _aVascular Endothelial Growth Factor A
_xantagonists & inhibitors
700 1 _aBrown, David M
700 1 _aCroft, Daniel E
700 1 _aMajor, James C
700 1 _aWong, Tien P
773 0 _tRetina (Philadelphia, Pa.)
_gvol. 35
_gno. 1
_gp. 43-7
856 4 0 _uhttps://doi.org/10.1097/IAE.0000000000000277
_zAvailable from publisher's website
999 _c24078742
_d24078742